跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 221,537 条关于
“moderate to severe persistent asthma”
全部
221,537
临床试验
177,750
药物
2,338
机构
674
资讯
40,775
9个月前
FDA Approves 300mg Strength of Celltrion's OMLYCLO, First Interchangeable Biosimilar to Xolair
11个月前
Amneal Submits BLA for Omalizumab Biosimilar to Challenge $4.1 Billion XOLAIR Market
去年
FDA Approves Novel Therapies for Frostbite, Food Allergies, and Synovial Sarcoma in 2024
去年
Rademikibart Shows Unprecedented 420mL Lung Function Improvement in Phase 2 Asthma Trial
去年
High Blood Eosinophils and FeNO Levels Predict Better Dupilumab Response in Moderate-to-Severe Asthma
去年
FDA Approves First Xolair Biosimilar Omlyclo for Allergic Diseases, Marking Milestone in Allergy Treatment Access
去年
RAPT Therapeutics Initiates Phase 2a Trial of RPT193 for Moderate-to-Severe Asthma
去年
Rocatinlimab Shows Significant SCORAD Improvement in Atopic Dermatitis Phase 2b Trial
2年前
FDA Approves Ebglyss (lebrikizumab-lbkz) for Moderate-to-Severe Atopic Dermatitis
去年
BOTOX® Cosmetic Receives FDA Approval for Platysma Bands
第 1 页，共 4078 页
上一页
下一页
